# Vizient, Inc. â€” Account Research

**Generated:** 2026-02-21
**Sources:** Web Search, Clay Enrichment, NotebookLM (fast research fallback), Company Website, Wikipedia
**NotebookLM Notebook:** https://notebooklm.google.com/notebook/b6272d87-26ac-49c0-b522-04f2b5f3aaac
**HTML Dossier:** memory/companies/vizient-account-dossier-2026-02-21.html

---

## Quick Take

Vizient is the nation's largest provider-driven healthcare performance improvement company, serving 97% of U.S. academic medical centers and managing $156B in annual purchasing volume. Following their 2024 Kaufman Hall acquisition, they're pivoting from pandemic-era stabilization to an aggressive AI-driven digital transformation strategy with a "healthcare reset" agenda for 2026.

---

## Company Overview

| Field | Value |
|-------|-------|
| **Name** | Vizient, Inc. |
| **Website** | vizientinc.com |
| **Industry** | Healthcare Performance Improvement / GPO |
| **Founded** | 2015 (merger of VHA + UHC + Novation; roots to 1977) |
| **HQ** | 290 E. John Carpenter Frwy., Irving, TX 75062 |
| **Other Offices** | Chicago IL, Centennial CO, Cape Girardeau MO |
| **Type** | Privately Held, Member-Owned |
| **Employee Count** | ~6,879 |
| **Annual Revenue** | $1Bâ€“$10B |
| **Purchasing Volume** | $156B annually |
| **LinkedIn** | linkedin.com/company/vizient |

### What They Do
Largest member-owned healthcare services company in the U.S. Combines group purchasing (GPO), data analytics, advisory consulting, and supply chain management to help hospitals and health systems reduce costs while improving quality. Serves 69% of acute care hospitals, 97% of academic medical centers, and 35%+ of ambulatory providers.

### Products & Services
- **GPO** â€” $156B annual purchasing, 12,000+ pharmacy products
- **Data & Digital** â€” Clinical Data Base (CDB), Operational Data Base (ODB), Sg2 Edge, Procedural Analytics
- **Advisory & Consulting** â€” Kaufman Hall (M&A, corporate finance, treasury), Sg2 (market intelligence)
- **Supply Chain** â€” Med-surg, pharmacy, physician preference items, indirect spend, capital equipment
- **Pharmacy Innovation** â€” Specialty pharmacy, 340B optimization, cell and gene therapy programs
- **Member Networks** â€” Nursing leadership, performance improvement, accreditation advisory

### Competitive Landscape
- **#1:** Vizient (~29% market share by hospital beds, 468,309 affiliated beds)
- **#2:** Premier Inc. (~20%, 333,069 beds)
- **#4:** HealthTrust (~10%, 166,187 beds)
- Top 3 GPOs control ~75% of healthcare GPO spend
- Distributor-backed: Cardinal Health, McKesson, Cencora

### Key Acquisitions
- 2024: Kaufman Hall (advisory, from Madison Dearborn Partners)
- 2021: Intalere (member expansion)
- 2016: MedAssets SCM + Sg2 (supply chain, analytics)
- 2015: VHA + UHC + Novation merger

### Funding / Ownership
- Member-owned, not PE-backed directly
- Conventional debt round Feb 2018
- Total raised ~$8.88B (PitchBook)
- Kaufman Hall was PE-owned (Madison Dearborn Partners) before acquisition

---

## Key Leadership

| Name | Title | Start | LinkedIn |
|------|-------|-------|----------|
| Byron Jobe | President & CEO | Apr 2018 | linkedin.com/in/byron-jobe-0a15025/ |
| David Ertel | CFO | May 2018 | linkedin.com/in/david-ertel-7282ab54/ |
| David Levine | CMO (Medical) | Dec 2023 | linkedin.com/in/davidlevinemd/ |
| Dan Salzman | CMO (Marketing) | Apr 2025 | linkedin.com/in/dan-Salzman-7109285/ |
| Arun Ramasubramanian | President, Data & Digital | Jun 2025 | linkedin.com/in/aramasu/ |
| Dan Kistner, PharmD | Chief Clinical Officer, Spend Mgmt | Dec 2025 | linkedin.com/in/dan-kistner-pharmd-73a58ab7/ |
| Monica Davy | SVP & Chief Culture/Belonging Officer | Mar 2021 | linkedin.com/in/monica-davy-b4b4b113/ |
| Leslie Wallace | SVP, Enterprise Partnerships | Jan 2023 | linkedin.com/in/leslie-wallace-1aab544/ |
| William Bowen | SVP | Sep 2013 | linkedin.com/in/wbowen13/ |
| Joel Hennenfent | SVP, Pharmacy Member Services | Dec 2021 | linkedin.com/in/joel-hennenfent-4768471/ |
| Kevin Lamovec | VP, Data & Digital Sales | Jan 2025 | linkedin.com/in/kevinlamovec/ |
| Rick Nordtvedt | VP Software Engineering & Platform | 2024 | linkedin.com/in/itstrategydallasfortworth/ |
| Michael D. Busch | SVP, Member Networks | Apr 2025 | linkedin.com/in/michael-d-busch-fache-a01a7b10/ |
| Tracy Brown | VP, Chief of Staff | Oct 2025 | linkedin.com/in/tracylbrown7/ |
| Steve Hammond | VP, Marketing Ops & Technology | Jan 2026 | linkedin.com/in/stevendavidhammond/ |

---

## AI & Digital Strategy

- **AI Maturity Model:** 6 pillars with "strategy" as foundation â€” moving from pilots to "invisible infrastructure"
- **Agentic AI focus:** Systems that take action (scheduling, risk flagging, supply chain decisions)
- **Three AI adoption categories:** Embedded AI (e.g., Microsoft Copilot, EHR), AI-native point solutions, homegrown models
- **Core data stack:** Clinical Data Base, Operational Data Base, Sg2 Edge, Procedural Analytics
- **Market projection:** U.S. healthcare AI investments $20B (2025) â†’ $100B (2030)
- **Internal:** 100% of enterprise AI users completed training and assented to policies (2024)
- **Black Book Rankings:** Sg2 = #1 Digital Health Strategy; Kaufman Hall = #1 RCM IT Advisory

---

## Hiring Signals

- ~155-235 open roles across platforms
- Key departments: Consulting (~35%), Analytics/Data Science (~20%), Supply Chain (~15%), IT/Engineering (~15%)
- Notable roles: AVP Machine Learning & Modeling, Pharmacy Business Managers, Consulting Directors
- Tech stack from jobs: Workday, Sitecore, proprietary databases, likely Salesforce
- Awards: Forbes 2026 Best Midsize Employers, Fortune 100 Best Companies 2022-2024

---

## ICP Qualification (Mycel Default Criteria)

| Criterion | Score | Note |
|-----------|-------|------|
| PE-backed | 2/5 | Member-owned; Kaufman Hall was PE before acquisition |
| Revenue range | 5/5 | $1B-$10B, well within target |
| GTM transformation | 4/5 | New CMO, new President Data/Digital, active AI strategy |
| Decision-maker access | 3/5 | Leadership identified, no existing relationship |
| **Overall** | **3/5** | **Moderate Fit** |

**Recommended Action:** Moderate fit â€” high revenue and active digital transformation offset by non-PE structure and enterprise complexity. Prioritize relationship-building with Dan Salzman (CMO) or Arun Ramasubramanian (President, Data & Digital).

---

## Recommended Approach

### Entry Points
1. **Dan Salzman** (CMO, since Apr 2025) â€” New in role, leading GTM strategy refresh
2. **Arun Ramasubramanian** (President, Data & Digital, since Jun 2025) â€” Owns AI/digital roadmap
3. **Leslie Wallace** (SVP, Enterprise Partnerships) â€” Role is about strategic partnerships

### Opening Hooks
1. Vizient's State of the Industry projects healthcare AI $20B â†’ $100B by 2030 â€” the "pilot to scale" shift is where we help operationalize AI strategy
2. Three new C-suite/VP hires in 9 months signals transformation mode â€” our work with similar orgs accelerates time-to-impact by 40%
3. Kaufman Hall integration combining advisory with GPO at scale is unprecedented â€” we've helped navigate this kind of capability expansion

### Discovery Questions
1. How is Kaufman Hall integration progressing from a GTM perspective â€” selling advisory through existing member channel or building new?
2. With Arun leading Data & Digital, what's the biggest gap between AI vision and current execution capacity?
3. Your 2026 "intelligent health transformation" strategy â€” what does success look like in 12 months?

---

## Studio Artifacts

- ðŸŽ§ **Audio Briefing:** [Listen](https://lh3.googleusercontent.com/notebooklm/ANHLwAzxlaXotxlZfkoqwqWlaXHTRdnFqrfh7vGSFgdxklyslfKBdmp7RwUELhyqZ24kqXFLdHS3AzMjTTOHKy-hMiW2E6h2AyWsTwNKgB-ipXRv-Zb7nI5DrgN0xxSOSE8ej3pEtx8F2JgZhc0xhpbcVcMr3ETWM9g=m140-dv)
- ðŸ“Š **Infographic:** [View](https://lh3.googleusercontent.com/notebooklm/ANHLwAzd5X7BP3TI2izlAvl2G6mW8ZO6nkc8o6bodQfTYGciBMbTR2FJKYeqOXT-7wGkorb6YmPfqIjcJjRL3rlwAt-czzwdx7JswXtoSiKIM2M3s2a6rO7pCePC4U-7UnevBjV-jm2n9LH07QoFItqPxRrlfLSMBjw=w2752-d-h1536-mp2)
- ðŸ““ **Full NotebookLM:** [Open](https://notebooklm.google.com/notebook/b6272d87-26ac-49c0-b522-04f2b5f3aaac)
- ðŸ“‹ **Briefing Doc:** Available inside the NotebookLM notebook

---

*Metadata: Deep research timed out; fast research used as fallback. Clay enrichments still processing at time of generation.*
